Abstract 9688: Predictors and Prognostic Significance of Recovery After Severe Right Ventricular Dysfunction
Abstract
Background: Right ventricular dysfunction (RVD) is a key determinant of morbidity and mortality across various cardiopulmonary diseases. Severe RVD is associated with poor outcomes, yet rates and predictors of right ventricular (RV) function recovery remain poorly defined. Hypothesis: Severe RVD has variable recovery depending on its etiologies, and recovery can be predicted by baseline clinical and echocardiographic parameters. Methods: Retrospective study of patients with severe RVD on index transthoracic echocardiogram (TTE) with follow-up TTE 30 to 365 days later. Those with interval heart transplant or left ventricular assist device were excluded. Etiology of RVD was categorized as left-sided heart disease (LHD), pulmonary arterial hypertension (PAH), lung disease, chronic thromboembolic pulmonary hypertension (CTEPH)/acute pulmonary embolism (PE), or other. Recovery was defined as normalization of RV function on follow-up TTE and summarized with cumulative incidence accounting for the competing risk of death. Baseline clinical and echocardiographic predictors of recovery were assessed using multivariable models. All-cause mortality was evaluated by Kaplan-Meier analysis. Results: Among 430 patients with severe RVD (mean age 60±16 years, 38% female), the most common etiology was LHD (49%), followed by PAH (19%), CTEPH/PE (16%), lung disease (11%), and other (5%). Overall, 91 patients experienced RV recovery with a 6-month estimated incidence of 13.3%. Six-month recovery estimates varied by etiology and were highest in CTEPH/acute PE (29.4%; 95% CI 19.8-43.6), followed by LHD (15.4%; 95% CI 10.8-21.9), other etiologies (9.1%; 95% CI 2.3-35.2), and lung disease (6.8%; 95% CI 2.2-20.7); no patients with PAH recovered by 6 months. In univariable analysis, recovery was associated with lower RVSP, smaller RV size, and more favorable RV-PA coupling indices, including TAPSE/RVSP and RV strain/RVSP ratios (Table). In multivariable modeling, younger age (HR 0.84 [0.72-0.98], p=0.02), higher heart rate (HR 1.02 [1.00-1.03], p=0.01), lower RVSP (HR 0.97 [0.96-0.99], p=0.0002), and smaller RA volume (HR 0.98 [0.97-0.99], p<0.0001) were independently associated with RV recovery. After follow-up TTE, 221 patients died over a median of 5.7 (IQR 1.4, 10.5) years. Failure of RV function to recover was associated with higher 5-year mortality (HR 3.21 [2.07-4.99], p<0.001, Figure). Conclusion: RV recovery occurred in 13% of patients with severe RVD at 6-month follow-up and was associated with etiology, younger age, lower RVSP, and smaller RA volume. Recovery was most common in CTEPH/PE and least common in those with PAH and lung disease, suggesting recovery reflects disease reversibility and severity of right heart remodeling. RV recovery on follow-up TTE was associated with improved 5-year survival, supporting its prognostic value.